155 related articles for article (PubMed ID: 22139643)
21. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis.
Fu X; Han Y; Wu Y; Zhu X; Lu X; Mao F; Wang X; He X; Zhao Y; Zhao Y
Eur J Clin Invest; 2011 Nov; 41(11):1245-53. PubMed ID: 21521185
[TBL] [Abstract][Full Text] [Related]
22. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.
Luo Y; Fu SJ; She DL; Xiong HU; Yang LI
Mol Clin Oncol; 2015 Jul; 3(4):924-928. PubMed ID: 26171208
[TBL] [Abstract][Full Text] [Related]
23. Elevated YKL-40 expression is associated with a poor prognosis in breast cancer patients.
Wan G; Xiang L; Sun X; Wang X; Li H; Ge W; Cao F
Oncotarget; 2017 Jan; 8(3):5382-5391. PubMed ID: 28036271
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
Shim SR; Kim SJ; Kim SI; Cho DS
World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
[TBL] [Abstract][Full Text] [Related]
28. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
Wang X; Liu S; Zhao X; Fang E; Zhao X
PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
[TBL] [Abstract][Full Text] [Related]
29. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
[TBL] [Abstract][Full Text] [Related]
30. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis.
Wang Y; Zhang Y; Pan C; Ma F; Zhang S
PLoS One; 2015; 10(2):e0118647. PubMed ID: 25706383
[TBL] [Abstract][Full Text] [Related]
31. Efficiency of C-reactive protein in prognosis evaluation of prostate cancer: a systematic review and meta-analysis.
Du J; Lan J; Xiong J; Yang H; Xu X; Tang C; Huang G; Ying Q; Mu J; Hu Q
Transl Cancer Res; 2021 Oct; 10(10):4432-4439. PubMed ID: 35116300
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Fang JM; Xiao YY; Zhao Y; Cui R; Hu F; Xu Q
Int J Clin Exp Med; 2015; 8(2):2289-98. PubMed ID: 25932165
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.
Chen J; Deng Q; Pan Y; He B; Ying H; Sun H; Liu X; Wang S
FEBS Open Bio; 2015; 5():502-7. PubMed ID: 26137435
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer.
Takeuchi H; Kawanaka H; Fukuyama S; Kubo N; Hiroshige S; Yano T
PLoS One; 2017; 12(5):e0177137. PubMed ID: 28489884
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis.
Yu X; Zhang X
Biomark Med; 2024 Apr; ():. PubMed ID: 38639733
[No Abstract] [Full Text] [Related]
36. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis.
Li W; Luo X; Liu Z; Chen Y; Li Z
PLoS One; 2018; 13(4):e0195769. PubMed ID: 29668751
[TBL] [Abstract][Full Text] [Related]
38. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract][Full Text] [Related]
39. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis.
Hong L; Yang J; Han Y; Lu Q; Cao J; Syed L
Gene; 2012 Oct; 507(2):135-8. PubMed ID: 22842193
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
Andersen HH; Bojesen SE; Johansen JS; Ejlertsen B; Berg T; Tuxen M; Madsen K; Danø H; Flyger H; Jensen MB; Nielsen DL
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):662-670. PubMed ID: 38358318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
